St. Jude Children’s Research Hospital has appointed Barry Whyte, Ph.D., as vice president of Communications and Public Relations. Whyte brings to the role an international perspective to the communication of scientific research as well as proven leadership skills from prestigious research and academic institutions.
“As advances occur in the fight against childhood cancer and other life-threatening diseases, Barry will help us share the excitement of discovery and communicate the story of St. Jude,” said James R. Downing, M.D., St. Jude president and chief executive officer.
Prior to joining St. Jude, Whyte served as head of public relations and communications for the European Molecular Biology Organization (EMBO) in Germany where he was responsible for a communication program to promote excellence in life sciences. Whyte also serves as an advisory panel member for the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden where he advises on public relations activities.
He received a bachelor of sciences and a doctorate in biochemistry from the University of Bristol, England.
St. Jude Children’s Research Hospital
St. Jude Children’s Research Hospital is leading the way the world understands, treats and cures childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food — because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow the hospital on Twitter and Instagram at @stjuderesearch.